Guggenheim Assumes Nuvalent at Buy, Announces Price Target of $99
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Kelsey Goodwin has initiated coverage on Nuvalent (NASDAQ:NUVL) with a Buy rating and set a price target of $99.
February 28, 2024 | 7:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim analyst Kelsey Goodwin has given Nuvalent a Buy rating and set a price target of $99.
Analyst ratings, especially from reputable firms like Guggenheim, can significantly influence investor sentiment and stock prices. A Buy rating combined with a high price target suggests a strong bullish outlook for Nuvalent, likely leading to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100